Status:
UNKNOWN
Supermicrosurgical Lymphvenous Bypass Intervention for Treatment
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Lymphedema of Leg
Eligibility:
All Genders
18-100 years
Brief Summary
Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic f...
Eligibility Criteria
Inclusion
- Lower limb lymphedema patients.
Exclusion
- Patients who have had previous LVA, liposuction, or excisional therapy such as the Charles procedure were excluded.
Key Trial Info
Start Date :
September 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 5 2022
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT05270629
Start Date
September 6 2021
End Date
September 5 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301